Related Experiment Video
Updated: Apr 12, 2026

Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
Periocular Squamous Cell Carcinoma: TNM Staging and Recurrence
Michelle T Sun1, Nicholas H Andrew1, Brett O'Donnell2
1South Australian Institute of Ophthalmology, University of Adelaide, Adelaide, South Australia, Australia.
Higher T stage eyelid squamous cell carcinoma (SCC) is linked to local recurrence. Recurrent SCC has a fourfold higher risk of recurrence than primary tumors, emphasizing vigilant follow-up.
Area of Science:
- Ophthalmology
- Oncology
- Dermatology
Background:
- Eyelid squamous cell carcinoma (SCC) is a common malignancy.
- Accurate staging and understanding recurrence patterns are crucial for effective management.
Purpose of the Study:
- To analyze the TNM stage, management strategies, and recurrence rates of patients with histologically confirmed eyelid SCC.
- To identify factors associated with recurrence in eyelid SCC.
Main Methods:
- A retrospective case series was conducted across three Australian centers.
- 254 patients with eyelid SCC were analyzed using the AJCC 7th edition TNM staging criteria.
- Outcomes and recurrence rates were evaluated based on TNM stage at presentation.
Main Results:
- Local recurrence occurred in 6.8% of treated patients, with a significantly higher rate in recurrent tumors (20%) versus primary tumors (5.3%).
- Higher T stage was significantly associated with perineural invasion (PNI) and local recurrence.
- No T-stage threshold was identified below which recurrence was impossible, with three T1 primary tumors recurring.
Conclusions:
- Higher T stage is a significant predictor of local recurrence in eyelid SCC.
- Recurrent tumors face a substantially increased risk of subsequent recurrence compared to primary tumors.
- Consideration of sentinel lymph node biopsy or close nodal surveillance is advised for high T-stage or recurrent tumors.
More Related Videos
07:44Translationally-Relevant Tumor Resection Model for Murine Preclinical Models of Oral Squamous Cell Carcinoma
Published on: April 3, 2026
07:29Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019